Koet 4 Winter Solstice Rituals From Around the World
Panuvitch Wuttichaikitjaroen/Getty ImagesNine months ago, Intel made Altera -- its unit that produces programmable chips -- a standalone xA0; business -- with the intention of spinning it public in 2026. xA0;On Monday, Altera executives showed off new chips at their annual developer conference, making the case for why Altera will dominate programmable chips in years to come.Also: Your next l
stanley thermos aptop may be powered by this Intel AI chip, and the benefits are mind-blowing Altera CEO Sandra Rivera Intel Our goal is to be the number one FPGA solutions provider in the world, said Altera CEO Sandra Rivera in a press briefing. Itapos a big, audacio
stanley cup price us, ambitious goal, but itapos the right goal for us since weapos;re the only company left in the world that is top to bottom, cloud to edge, FPGAs, said Rivera, referring to field-programmable gate arrays -- the programmable chips used across virtually every product in the world that uses chips.Al
stanley mug tera, acquired by Intel in 2015 for $15 billion, is one of a triumvirate of programmable chip makers that came to market in the 1980s, the other two being Xilinx, which was acquired last year by Intelapos arch-rival, Advanced Micro Devices, and Lattice Semiconductor, which remains independent. xA0;The plan, said Rivera, is to take Altera public in 2026, which is a very fun and important milestone, she said, but our our journey really is what happens throughout the next number of year Oqzt DLA Information Operations program executive officer discusses teaming effort to support DLA Distribution s modernization journey
By Alexandra SifferlinJanuary 19, 2016 3:28 PM ESTResearchers have identified a gene mutation that can increase a woman risk of developing ovarian cancer.In a new study, published in the Journal of the National Cancer Institute, researchers found that mutations in a gene called BRIP1 raised a woman chance of getting ovarian cancer in her lifetime to approximately 5%. That nearly three times greater than t
stanley quencher he 1.8% chance women generally have of developing the cancer, making the new findings significant.The risk isnrsquo;t very high on its own, but a 5% risk of ovarian cancer is not a trivial risk, says Paul Pharoah, a professor of cancer e
stanley cup pidemiology at the Cancer Research UK Cambridge Institute.To reach these findings, the scientists examined genes on DNA samples from more than 8,000 women. Around 3,250 women had ovarian cancer, about 3,400 did not have cancer and 2,000 of the women did not have cancer but did have a family history of ovarian cancer.The researchers looked at four different genes which, in the past
stanley deutschland , had been found to possibly be associated with a higher risk for cancer: BRIP1, BARD1, PALB2 and NBN. The BRIP1 gene, for example, had been found in an Icelandic study to be linked to a higher risk for ovarian cancer among women with a mutation specific to that population. However, until now it wasn ;t certain if the effects translated to other populations.The researchers found that mutations in BRIP1 were associated with a
